AIDS policy: two divisive issues
Article Abstract:
The US National Commission on AIDS released its final report on the HIV epidemic. The federal government established this commission in 1989 to oversee AIDS policy. Two other government reports have given rise to two important questions concerning the prevention of HIV infection. One is whether preventive programs should be aimed at high risk groups and neighborhoods rather than the general population. This approach ignores the vulnerability of the entire population to HIV infection. It also creates a false sense of security among lower-risk individuals. Another question is whether needle and syringe exchange programs should be legalized and encouraged. One-third of new HIV infections are associated with intravenous drug use and needle-exchange programs probably do not increase the use of intravenous drugs. They may decrease high risk behavior and help drug addicts enroll in a drug treatment program. The chairman of the House Select Committee on Narcotics Abuse and Control, Rep Charles B. Rangel, remains opposed to needle exchange programs.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
Scale-up of voluntary HIV counseling and testing in Kenya
Article Abstract:
The impact of human immunodeficiency virus (HIV) has overburdened the health care systems in resource-poor countries and hence it is proposed internationally to increase responses to treatment. It is learnt that from increasing access to voluntary HIV counseling and testing (VCT) provides for the expansion of antiretroviral therapy (ART)-related care, the need for quality assurance systems, supportive policies and innovative practices responsive to patients needs.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Preexposure prophylaxis for HIV: Unproven promise and potential pitfalls
Article Abstract:
A promising new biomedical strategy, preexposure chemoprophylaxis (PrEP) has emerged for preventing HIV infection and is being planned in clinical trials to evaluate the safety and efficacy of this approach. It is suggested that PrEP clinical trials should proceed quickly to provide the evidence required for informed counseling about PrEP.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Publicly funded HIV counseling and testing - United States, 1991. Effect of HIV Reporting by Name on Use of HIV Testing in Publicly Funded Counseling and Testing Programs
- Abstracts: A 43-year-old Cambodian man with several years of recurrent bouts of fever and abdominal pain. Repeated bouts of hematochezia in a 80-year-old hypertensive man
- Abstracts: A dry run. A guide to selecting and using urinary sheaths. Timely intervention
- Abstracts: Assessment of cutaneous sensory and autonomic axon reflexes in rheumatoid arthritis. Rheumatoid arthritis, the contraceptive pill, and androgens
- Abstracts: A successful system of scientific data audits for clinical trials: a report from the Cancer and Leukemia Group B